At the time of writing, Insmed Inc [INSM] stock is trading at $158.28, up 0.71%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The INSM shares have gain 11.74% over the last week, with a monthly amount glided 9.08%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Morgan Stanley downgraded its rating to Equal-Weight on August 13, 2025, and kept the price target unchanged to $126. On May 13, 2025, Jefferies initiated with a Buy rating and assigned a price target of $105 on the stock. RBC Capital Mkts started tracking the stock assigning a Outperform rating and suggested a price target of $100 on February 25, 2025. Truist initiated its recommendation with a Buy and recommended $48 as its price target on April 23, 2024. Wolfe Research started tracking with a Outperform rating for this stock on February 15, 2024, and assigned it a price target of $42. In a note dated December 08, 2023, Wells Fargo initiated an Overweight rating and provided a target price of $55 on this stock.
For the past year, the stock price of Insmed Inc fluctuated between $60.40 and $158.19. Currently, Wall Street analysts expect the stock to reach $160 within the next 12 months. Insmed Inc [NASDAQ: INSM] shares were valued at $158.28 at the most recent close of the market. An investor can expect a potential return of 1.09% based on the average INSM price forecast.
Analyzing the INSM fundamentals
According to Insmed Inc [NASDAQ:INSM], the company’s sales were 398.11M for trailing twelve months, which represents an 18.90% jump. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at -2.38%, Pretax Profit Margin comes in at -2.59%, and Net Profit Margin reading is -2.6%. To continue investigating profitability, this company’s Return on Assets is posted at -0.42, Equity is -1.95 and Total Capital is -0.44. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.46.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 156.60 points at the first support level, and at 154.91 for the second support level. However, for the 1st resistance point, the stock is sitting at 160.29, and for the 2nd resistance point, it is at 162.30.
Ratios To Look Out For
It is important to note that Insmed Inc [NASDAQ:INSM] has a current ratio of 6.68. Further, the Quick Ratio stands at 6.33, while the Cash Ratio is 4.12. Considering the valuation of this stock, the price to sales ratio is 84.04, the price to book ratio is 26.74.
Transactions by insiders
Recent insider trading involved Schaeffer Orlov S Nicole, Chief People Strategy Officer, that happened on Sep 12 ’25 when 76520.0 shares were sold. Director, SHAROKY MELVIN MD completed a deal on Sep 12 ’25 to sell 10000.0 shares. Meanwhile, Officer Schaeffer Orlov S Nicole bought 76520.0 shares on Sep 12 ’25.
